Institutional investors purchased a net $852.9 thousand shares of MYL during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 76.53% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Generic industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEXAVEST, INC. Bought 1.3 Million shares of Mylan NV
ASSENAGON ASSET MANAGEMENT SA (G... Bought 738.5 Thousand shares of Mylan NV